Gilpin Wealth Management’s DexCom DXCM Stock Holding History

Gilpin Wealth Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$472	Hold	7	–	–	﹤0.01%	695
2026 Q1	$440	Buy	+7	New	+$487	﹤0.01%	652

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Gilpin Wealth Management's DXCM Position: Q2 2026 in Review

Gilpin Wealth Management held its DexCom (DXCM) position steady in Q2 2026 at 7 shares worth $472. The position accounts for ﹤0.01% of the portfolio, ranked #695.

Gilpin Wealth Management first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Gilpin Wealth Management held 7 shares of DexCom worth $472 as of Q2 2026.
Gilpin Wealth Management left its DexCom share count unchanged in Q2 2026.
DexCom made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q2 2026, its #695 holding.
Gilpin Wealth Management first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Gilpin Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.